#United Arab Emirates #Dubai #Myant #Textile Computing #Arab Health

Myant Transforming Healthcare at Arab Health 2025

At the upcoming Arab Health 2025 event, Myant will illuminate its commitment to revolutionizing healthcare through innovative technology designed for continuous, human-centric, and preventive care. This major healthcare exhibition, known as the largest in the Middle East, will serve as a critical platform for Myant to showcase its cutting-edge advancements in AI and Textile Computing™.

The company's primary offering, Myant Care, is an integrated health management platform that aims to predict and prevent diseases. By harnessing clinical-grade interfaces and applying deep machine learning, Myant Care processes continuous health data alongside scientific literature to develop actionable health plans. This proactive approach empowers individuals to maintain better health, potentially leading to enhanced quality of life.

A standout feature of Myant Care is the Skiin Generation 2, touted as the world's first passive medical-grade remote monitor designed for daily use. Skiin seamlessly integrates various health metrics such as electrocardiograms (ECG), cuffless blood pressure readings, and sleep apnea diagnostics, delivering valuable insights into managing chronic conditions like hypertension, heart failure, and chronic obstructive pulmonary disease (COPD).

The data collected by Skiin provides physicians with vital information, transforming remote consultations by enabling live telemetry and symptom replay, thus promoting a more proactive and continuous patient-physician relationship. This marks a substantial shift from conventional episodic care to a more comprehensive understanding of patient health based on real-time data.

In addition to these advancements, Myant will highlight its role within the Ontario Pavilion at Arab Health 2025. This participation is part of the Life Sciences Export Mission supported by the Government of Ontario, aiming to foster strategic partnerships within the Gulf Cooperation Council (GCC) area. Through this mission, Myant intends to expand its influence in the Middle East's healthcare landscape and solidify Ontario's status as a vital hub for health technology innovation.

Myant is poised to announce significant strategic initiatives, including its plan to raise $250 million in a Series C funding round, which will enhance its efforts to serve one million patients in the region. This ambition reinforces Myant's position as a pioneering entity in the integration of technology and healthcare, driven by a commitment to making disease prevention accessible and efficient.

As Myant embarks on this journey, it invites attendees to visit their stand (#H7.B50) at the Dubai World Trade Center from January 27 to 30, 2025, to witness firsthand its contributions to the future of healthcare. For more information about Myant and its offerings, please visit www.myant.ca.

The company envisions a world where AI guardians enhance human capabilities through innovative textile technologies that serve as a second skin, integrating seamlessly into everyday life. By doing so, Myant is not only setting a new standard for healthcare delivery but is also enabling universal access to quality medical care, ensuring safety and connection throughout every stage of life. In 2024, Myant's growth in the EU market was highlighted by the addition of Dr. Xin Gao, a renowned AI scientist, as Chief AI Officer, further positioning the company at the forefront of health technology.

Myant's participation in Arab Health 2025 exemplifies its dedication to leveraging breakthroughs in AI and materials science, propelling healthcare into a proactive future where preventive measures take precedence. As global leaders in healthcare gather, Myant is primed to lead conversations about the future of personal health management and disease prevention strategies that resonate deeply with health stakeholders attending the event.